Robeco Institutional Asset Management’s ADMA Biologics ADMA Stock Holding History

Robeco Institutional Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-258,609	Closed	-$5.13M	–	862
2025 Q1	$5.13M	Buy	258,609 +84,125	+48%	+$1.45M	0.01%	569
2024 Q4	$2.99M	Sell	174,484 -4,600	-3%	-$86.5K	0.01%	642
2024 Q3	$3.58M	Buy	179,084 +68,000	+61%	+$1.06M	0.01%	611
2024 Q2	$1.24M	Buy	+111,084	New	+$932K	﹤0.01%	754
2023 Q3	–	Sell	-10,938	Closed	-$40.4K	–	1016
2023 Q2	$40.4K	Hold	10,938	–	–	﹤0.01%	1013
2023 Q1	$36.2K	Hold	10,938	–	–	﹤0.01%	1023
2022 Q4	$42.4K	Buy	+10,938	New	+$33.7K	﹤0.01%	934

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Robeco Institutional Asset Management's ADMA Position: Q2 2025 in Review

Robeco Institutional Asset Management sold out of ADMA Biologics (ADMA) in Q2 2025, closing a stake of 258,609 shares — an estimated $5.13M sold.

Robeco Institutional Asset Management first reported a position in ADMA in Q4 2022 and held it in 7 quarters. The position peaked at $5.13M in Q1 2025. 368 funds tracked by Wall St. Rank hold ADMA as of Q2 2025.

Robeco Institutional Asset Management reported no remaining ADMA Biologics position as of Q2 2025 after selling out during the quarter.
Robeco Institutional Asset Management sold 258,609 ADMA Biologics shares in Q2 2025, an estimated $5.13M.
Robeco Institutional Asset Management first reported a position in ADMA Biologics in Q4 2022 and held it in 7 quarters.
Robeco Institutional Asset Management's ADMA Biologics position peaked at $5.13M in Q1 2025.
368 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2025.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2025, filed 18 Jul 2025.